Edap Tms S.A. (NASDAQ:EDAP) Short Interest Up 163.4% in December

Edap Tms S.A. (NASDAQ:EDAP) saw a large increase in short interest in December. As of December 15th, there was short interest totaling 93,243 shares, an increase of 163.4% from the November 30th total of 35,401 shares. Based on an average daily trading volume, of 71,663 shares, the days-to-cover ratio is currently 1.3 days. Currently, 0.2% of the shares of the stock are sold short. Currently, 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 71,663 shares, the days-to-cover ratio is currently 1.3 days.

Wall Street Analyst Weigh In

Several brokerages have recently commented on EDAP. Jefferies Financial Group reissued a “hold” rating and issued a $2.00 target price on shares of Edap Tms in a report on Thursday, November 6th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Edap Tms in a report on Monday. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $8.50.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Simplicity Wealth LLC bought a new stake in shares of Edap Tms in the 2nd quarter valued at $54,000. Sage Mountain Advisors LLC bought a new stake in Edap Tms during the 2nd quarter valued at $165,000. Scoggin Management LP bought a new position in Edap Tms in the 1st quarter valued at about $686,000. Finally, Banque Transatlantique SA boosted its position in shares of Edap Tms by 7,063.7% during the first quarter. Banque Transatlantique SA now owns 730,699 shares of the medical equipment provider’s stock valued at $1,324,000 after buying an additional 720,499 shares during the last quarter. Institutional investors own 62.74% of the company’s stock.

Edap Tms Stock Performance

Shares of Edap Tms stock traded up $0.41 during trading on Friday, hitting $3.38. 50,879 shares of the stock were exchanged, compared to its average volume of 81,067. The company has a fifty day moving average price of $2.37 and a 200-day moving average price of $2.04. The stock has a market capitalization of $126.19 million, a price-to-earnings ratio of -5.92 and a beta of -0.15. The company has a current ratio of 1.41, a quick ratio of 0.97 and a debt-to-equity ratio of 0.04. Edap Tms has a 1-year low of $1.21 and a 1-year high of $3.45.

Edap Tms (NASDAQ:EDAP) last released its quarterly earnings data on Thursday, November 6th. The medical equipment provider reported ($0.15) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.11. The company had revenue of $16.29 million during the quarter, compared to analysts’ expectations of $15.05 million. Edap Tms had a negative return on equity of 61.60% and a negative net margin of 30.95%. As a group, equities analysts predict that Edap Tms will post -0.6 EPS for the current fiscal year.

About Edap Tms

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.